PDCA在临床用血审核中的应用效果分析  

Analysis on the Effect of Applying PDCA in Clinical Blood Transfusion Approval

作　　者：徐红燕[1] XU Hong-yan(Tongde Hospital of Zhejiang Provinc)

机构地区：[1]浙江省立同德医院

出　　处：《医院管理论坛》2017年第9期42-45,48,共5页Hospital Management Forum

摘　　要：目的探讨基于PDCA循环的持续质量改进在临床用血审核、审批中的应用价值。方法回顾性分析输血科基于PDCA循环的持续质量改进(CQI)实施前后开具的458份与285份输血申请单,分析实施前后输血申请单审核合格率、存在问题率、临床科室用血考核成绩、合理输血率、输血适应证合格率与输血不良反应率等临床用血审核审批质量考核指标的差异。结果与基于PDCA循环的CQI实施前比较,实施后输血申请单审核合格率明显提高,输血申请单存在问题率明显降低,临床科室用血考核成绩优良率、合格输血率、输血适应证合格率明显提高,输血不良反应率明显低于实施前,实施前后比较差异具有统计学意义(P<0.05)。结论基于PDCA循环的持续质量改进在临床用血审核审批中的应用价值显著,值得临床推广应用。Objective To study the application value of continuous quality improvement（CQI） based on PDCA cycle in clinical blood transfusion examination and approval. Method Retrospective analysis was conducted on 458 and 285 copies of blood transfusion application before and after CQI based on PDCA cycle was applied, to analyze the difference in assessment indicators for clinical blood transfusion examination and approval, including blood transfusion application pass rate, blood transfusion application problem rate, performance of clinical departments in blood use, reasonable blood transfusion rate, rate of blood transfusion conforming to indications, and blood transfusion adverse reaction rate. Results After CQI based on PDCA cycle was applied, blood transfusion application pass rate, rate of good and moderate performance of clinical departments in blood use, reasonable blood transfusion rate, and rate of blood transfusion conforming to indications significantly increased, and blood transfusion application problem rate and blood transfusion adverse reaction rate significantly decreased（P〈0.05）. Conclusion CQI based on PDCA cycle was worthy of being applied in clinical blood transfusion approval and of being generalized.

关 键 词：持续质量改进 临床用血 审核 

分 类 号：R197.323[医药卫生—卫生事业管理]